Skip to main content

News Archive

News Archive - School of Medicine

UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread

December 7, 2018

David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.

Targeted Cognitive Training Benefits Patients with Severe Schizophrenia

December 6, 2018

Researchers find that patients with severe, refractory schizophrenia benefit from targeted cognitive therapy, improving auditory and verbal outcomes and the way they process information.

Half a Million Tests and Many Mosquitoes Later, New Buzz about a Malaria Prevention Drug

December 6, 2018

Researchers spent two years testing chemical compounds for their ability to inhibit the malaria parasite at an earlier stage in its lifecycle than most current drugs, revealing a new set of chemical starting points for the first drugs to prevent malaria instead of just treating the symptoms.

UC San Diego Researchers Develop Sensors to Detect and Measure Cancer’s Ability to Spread

December 5, 2018

University of California San Diego School of Medicine researchers engineered sensors to detect and measure the metastatic potential of single cancer cells. Metastasis is attributed as the leading cause of death in people with cancer.

UC San Diego Medical Center Named by Leapfrog as “2018 Top Teaching Hospital”

December 4, 2018

UC San Diego Medical Center in Hillcrest was named a Top Teaching Hospital by The Leapfrog Group. The award is widely acknowledged as one of the most competitive honors that a U.S. hospital can receive.

New Cancer Immunotherapy Approach Turns Immune Cells into Tiny Anti-Tumor Drug Factories

December 4, 2018

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs.

UC San Diego Health is First in San Diego to offer CAR T-cell Therapy for Some Cancers

December 3, 2018

Following the FDA’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.

Study: Immunotherapy Better than Chemotherapy for Subtype of Head and Neck Cancer

November 30, 2018

A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy.

New UC San Diego Campaign Promotes Sexual Health — and Has a Quick Test to Prove It

November 30, 2018

New UC San Diego campaign promotes sexual health and has a quick test to prove it. “Good to Go” offers combined testing for HIV and five sexually transmitted diseases, providing some results in as little as 60 seconds and access to free treatment, if needed. Updated clinic opening Dec. 10.

Prevention and Screening Clinic at UC San Diego Health Helping to Reduce Pancreatic Cancer

November 29, 2018

Moores Cancer Center at UC San Diego Health launched the Pancreatic Cancer Prevention and Screening Clinic in an attempt to reduce the number of people who develop the disease and improve survival for those who do. Every day in the U.S., 145 people are diagnosed and every 12 minutes someone dies.
Category navigation with Social links